These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16418399)

  • 1. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in Leishmania major infections: mechanisms of parasite uptake, cell activation and evidence for physiological relevance.
    Kautz-Neu K; Schwonberg K; Fischer MR; Schermann AI; von Stebut E
    Med Microbiol Immunol; 2012 Nov; 201(4):581-92. PubMed ID: 22983754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity.
    Dermicik F; Lopez Kostka S; Tenzer S; Waisman A; Von Stebut E
    J Mol Med (Berl); 2022 Mar; 100(3):451-460. PubMed ID: 34604942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions.
    Thomas BN; Buxbaum LU
    Infect Immun; 2008 Feb; 76(2):623-31. PubMed ID: 18070890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
    Lemos MP; Esquivel F; Scott P; Laufer TM
    J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
    Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
    PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous leishmaniasis: Distinct functions of dendritic cells and macrophages in the interaction of the host immune system with Leishmania major.
    von Stebut E; Tenzer S
    Int J Med Microbiol; 2018 Jan; 308(1):206-214. PubMed ID: 29129568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection.
    Hurdayal R; Nieuwenhuizen NE; Revaz-Breton M; Smith L; Hoving JC; Parihar SP; Reizis B; Brombacher F
    PLoS Pathog; 2013 Oct; 9(10):e1003699. PubMed ID: 24204259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H; Flohé S; Röllinghoff M
    Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.
    von Stebut E; Belkaid Y; Jakob T; Sacks DL; Udey MC
    J Exp Med; 1998 Oct; 188(8):1547-52. PubMed ID: 9782133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
    Erb K; Blank C; Ritter U; Bluethmann H; Moll H
    Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
    Okwor I; Jia P; Uzonna JE
    J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with TAT-antigen fusion protein induces protective, CD8(+) T cell-mediated immunity against Leishmania major.
    Kronenberg K; Brosch S; Butsch F; Tada Y; Shibagaki N; Udey MC; von Stebut E
    J Invest Dermatol; 2010 Nov; 130(11):2602-10. PubMed ID: 20574442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for leukocyte-derived IL-1RA in DC homeostasis revealed by increased susceptibility of IL-1RA-deficient mice to cutaneous leishmaniasis.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    J Invest Dermatol; 2011 Aug; 131(8):1650-9. PubMed ID: 21525884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 signalling is dispensable for protective immunity in Leishmania-resistant mice.
    Kautz-Neu K; Kostka SL; Dinges S; Iwakura Y; Udey MC; von Stebut E
    Exp Dermatol; 2011 Jan; 20(1):76-8. PubMed ID: 20955202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.